Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05943106
Title BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants (PATAPSCO)
Acronym PATAPSCO
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Phoenix Arizona 85054 United States Details
Research Site Little Rock Arkansas 72211 United States Details
Research Site San Diego California 92123 United States Details
Research Site Lakewood Colorado 80228 United States Details
Research Site Hialeah Florida 33016 United States Details
Research Site Jacksonville Florida 32209 United States Details
Research Site Greenwood Indiana 46143 United States Details
Research Site Wichita Kansas 67226 United States Details
Research Site Baltimore Maryland 21203 United States Details
Research Site Hanover Maryland 21076 United States Details
Research Site Royal Oak Michigan 48073 United States Details
Research Site Troy Michigan 48084 United States Details
Research Site Syracuse New York 13210 United States Details
Research Site Cincinnati Ohio 45212 United States Details
Research Site Bala-Cynwyd Pennsylvania 19004-1017 United States Details
Research Site Myrtle Beach South Carolina 29572 United States Details
Research Site Nashville Tennessee 37209 United States Details
Research Site Austin Texas 78745 United States Details
Research Site Spokane Washington 99202 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field